# The Human Medicines (Amendment etc.) (EU Exit) (No. 2) Regulations 2021, Regulation 10: Amendment of regulation 60A (condition as to the submitting of samples and other information to the appropriate authority)


(1) Regulation 60A is amended as follows.
(2) In paragraph (1), in the definition of “the batch testing exemption”, in paragraph (b)(ii), after “United Kingdom” insert “or, in the case of a product for sale or supply in Northern Ireland, the European Union”.
(3) In paragraph (2), in each place where it occurs, for “immunological product” substitute “immunological medicinal product”.

---
Source: https://www.legislation.gov.uk/ukdsi/2021/9780348228755/regulation/10 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-no-2-regulations-2021/regulation-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.